Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
Trump Announces Proposals to Make I.V.F. More Affordablenews2025-10-17T00:17:15+00:00October 17th, 2025|The New York Times|
How Private Equity Oversees the Ethics of Drug Researchnews2025-10-04T09:00:13+00:00October 4th, 2025|The New York Times|
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisisnews2025-09-23T04:39:03+00:00September 23rd, 2025|The New York Times|
La empresa detrás de Tylenol intenta sortear su crisis más recientenews2025-09-23T04:01:05+00:00September 23rd, 2025|The New York Times|
Walgreens to Be Acquired by Sycamore Partners in $10 Billion Dealnews2025-03-07T09:24:47+00:00March 7th, 2025|The New York Times|
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billionnews2023-12-22T17:55:31+00:00December 22nd, 2023|The New York Times|
Monsanto Should Pay $857 Million in PCB Case, Jury Findsnews2023-12-19T02:53:57+00:00December 19th, 2023|The New York Times|
Rite Aid Files for Bankruptcy, Facing Slumping Sales and Opioid Suitsnews2023-10-16T06:05:18+00:00October 16th, 2023|The New York Times|
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeuticsnews2023-05-16T18:16:56+00:00May 16th, 2023|The New York Times|
